These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Prevalence and risk factors associated with Leishmania infection in Trang Province, southern Thailand. Manomat J; Leelayoova S; Bualert L; Tan-Ariya P; Siripattanapipong S; Mungthin M; Naaglor T; Piyaraj P PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006095. PubMed ID: 29155831 [TBL] [Abstract][Full Text] [Related]
49. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238 [TBL] [Abstract][Full Text] [Related]
50. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection]. Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140 [TBL] [Abstract][Full Text] [Related]
51. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Pourahmad M; Hooshmand F; Rahiminejad M Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052 [TBL] [Abstract][Full Text] [Related]
52. Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010. Lima IP; Müller MC; Holanda TA; Harhay M; Costa CH; Costa DL Rev Soc Bras Med Trop; 2013; 46(2):156-60. PubMed ID: 23666663 [TBL] [Abstract][Full Text] [Related]
54. Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case report. Mestra L; Lopez L; Robledo SM; Muskus CE; Nicholls RS; Vélez ID Transfusion; 2011 Sep; 51(9):1919-23. PubMed ID: 21392021 [TBL] [Abstract][Full Text] [Related]
55. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections. Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637 [TBL] [Abstract][Full Text] [Related]
56. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Alborzi A; Rasouli M; Shamsizadeh A Am J Trop Med Hyg; 2006 Feb; 74(2):306-7. PubMed ID: 16474088 [TBL] [Abstract][Full Text] [Related]
57. [An adult case of visceral leishmaniasis in a province of Black-Sea region, Turkey]. Oztoprak N; Aydemir H; Pişkin N; Seremet Keskin A; Araslı M; Gökmen A; Celebi G; Külekçi Uğur A; Taylan Özkan A Mikrobiyol Bul; 2010 Oct; 44(4):671-7. PubMed ID: 21063981 [TBL] [Abstract][Full Text] [Related]
58. In vitro growth characteristics and morphological differentiation of Leishmania martiniquensis promastigotes in different culture media. Siripattanapipong S; Boontanom P; Leelayoova S; Mungthin M; Tan-Ariya P Acta Trop; 2019 Sep; 197():105039. PubMed ID: 31132335 [TBL] [Abstract][Full Text] [Related]
59. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. Chattopadhyay A; Jafurulla M Biochem Biophys Res Commun; 2011 Dec; 416(1-2):7-12. PubMed ID: 22100811 [TBL] [Abstract][Full Text] [Related]
60. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]